01:09:35duration 1 hour 9 minutes
Ron Evans - Cancer Course
UCSD Cancer Course
44:34duration 44 minutes 34 seconds
Tony Hunter - Perspectives on the science that…
Tony Hunter - Perspectives on the science that Salk has enabled me to do over the past 50 years and where it has led
Tony Hunter 50th Symposium
33:14duration 33 minutes 14 seconds
John Brognard - Tracking down the elusive dark…
John Brognard - Tracking down the elusive dark kinome to identify new cancer drug targets
42:16duration 42 minutes 16 seconds
Susan Taylor - How elucidating the structure of…
Susan Taylor - How elucidating the structure of the protein kinase A catalytic domain has enabled the development of selective kinase inhibitors
39:05duration 39 minutes 5 seconds
Lew Cantley - The discovery of PI-3 kinase and…
Lew Cantley - The discovery of PI-3 kinase and how tyrosine phosphorylation leads to PI-3 kinase signaling, and the development of PI-3 kinase inhibitors as cancer drugs
32:44duration 32 minutes 44 seconds
Sara Courtneidge - From the discovery that SRC is…
Sara Courtneidge - From the discovery that SRC is a membrane protein to its role in cell invasion through activating invadosome function
20:16duration 20 minutes 16 seconds
American Cancer Society Professor Tony Hunter -…
American Cancer Society Professor Tony Hunter - Podcast Season 1
Tony Hunter is an American Cancer Society…
17:53duration 17 minutes 53 seconds
Tony Hunter -It took you five years to start…
Tony Hunter -It took you five years to start working on RTKs after arriving at Salk in 1985 – the rest is history